Domenico Albano,Carlo Rodella,Andrea Guarneri et al.
Domenico Albano et al.
18F fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) has established itself as a fundamental non invasive diagnostic technique in the investigation of patients with fever (FUO) and inflammation of unkn...
Pitfalls and artifacts in [18F]-FDG PET imaging in children with lymphoma [0.03%]
儿童淋巴瘤患者中[18F]-FDG PET显像的局限性和假象
Domenico Albano,Alessio Rizzo,Carlo Rodella et al.
Domenico Albano et al.
Positron emission tomography/computed tomography (PET/CT) with 2-[fluorine-18]fluoro-2-deoxy-D-glucose ([18F]-FDG) is a well-established imaging tool in adult oncology and is increasingly utilized also in pediatric oncology due to its abili...
Stereotactic body radiation therapy for the re-irradiation of local relapse from prostate cancer: results in terms of outcomes and toxicity [0.03%]
立体定向身体放射治疗用于前列腺癌局部复发的再程放疗：疗效及毒副反应结果分析
Ciro Franzese,Raffaella Lucchini,Marco Badalamenti et al.
Ciro Franzese et al.
Background: The aim is to retrospectively evaluate toxicity and outcomes of re-irradiation (re-RT) for macroscopic local relapse in patients with prostate cancer (PCa) treated with previous definitive or postoperative rad...
The advent of Astatine-211 in targeted radionuclide therapy in prostate cancer: will it come to true fruition? [0.03%]
用于前列腺癌靶向放射性核素治疗的原子序数最大的自然元素砹-211：是否会真正实现？
Khanyisile N Hlongwa,Prudence M Rivombo,Stuart S More
Khanyisile N Hlongwa
With the growth and surge of prostate cancer theranostics globally, multiple targeted radionuclide therapy (TRT) agents have been utilized to aim to provide a tumoricidal effect to patients who would benefit from TRT. Despite the fact that ...
[18F]FDG and [68Ga]Ga-PSMA dual-tracer total-body PET/CT and PET/MR in patients with prostate cancer [0.03%]
前列腺癌患者的双示踪剂正电子发射断层扫描/X线计算机体层成像和正电子发射断层扫描/磁共振全身显影([18F]FDG和[68Ga]Ga-PSMA)
Yu Lin,Huaping Gao,Yunze Xie et al.
Yu Lin et al.
Prostate cancer (PCa) is a heterogeneous disease and prevalent malignancy in men, necessitating accurate imaging techniques to facilitate effective diagnosis and management. Recent evidence has demonstrated that [18F]fluorodeoxyglucose ([18...
Tumor sink effect in PSMA-targeted theranostics: intra-patient evaluation of a cohort receiving 225Ac/177Lu-PSMA tandem radioligand therapy [0.03%]
靶向PSMA治疗诊断的肿瘤sink效应：接受225Ac / 177Lu-PSMA联合放射配体治疗的患者的队列研究
Caroline Burgard,Marie D Muenzenberg,Arne Blickle et al.
Caroline Burgard et al.
Background: This study aims to further strengthen the evidence of tumor sink effect (TSE) and to confirm this phenomenon in patients undergoing 225Ac/177Lu-PSMA tandem radioligand therapy. ...
Navigating response criteria in mCRPC: role of PSMA PET/CT and new insights [0.03%]
探索mCRPC应对标准：PSMA PET/CT的作用及新见解
Angelo Castello,Matteo Caracciolo,Mirco Bartolomei et al.
Angelo Castello et al.
Metastatic castration-resistant prostate cancer (mCRPC) is an unavoidable advanced condition associated with short-term survival and poor prognosis. It is a heterogeneous disease, difficult to monitor based only on serum PSA levels. For thi...
Targeted alpha therapy in prostate cancer: review of available agents in clinical practice [0.03%]
前列腺癌靶向α治疗：临床实践中的药物疗效综述
Honest Ndlovu,Ismaheel O Lawal,Joseph Kabunda et al.
Honest Ndlovu et al.
Targeted alpha therapy (TAT) has shown promise in prostate cancer patients, both hormone-sensitive and castration-resistant, with or without prior treatment. TAT's radiobiological properties explain why it is more potent than other forms of...
PET imaging and radionuclide therapy in neuroendocrine prostate cancer: a systematic review [0.03%]
神经内分泌前列腺癌的正电子发射断层扫描影像和放射核素治疗：一项系统性综述
Ahmed S Abdlkadir,Dhuha Al-Adhami,Ula Al-Rasheed et al.
Ahmed S Abdlkadir et al.
Introduction: Neuroendocrine prostate cancer (NEPC) is a rare cancer subtype with significant prognostic implications. This systematic review aims to explore the current landscape of positron emission tomography (PET) ima...
Navigating the prostate cancer frontiers: charting new horizons in molecular imaging and targeted radionuclide therapy [0.03%]
前列腺癌的分子影像和靶向核素治疗的新视野
Akram Al-Ibraheem
Akram Al-Ibraheem